Quince Therapeutics, Inc.QNCXNASDAQ
Loading
ROIC: Returns DecliningContracting
Percentile Rank29
Studio
Year-over-Year Change

Return on invested capital

Latest
-53.39%
Near historical average
Percentile
P29
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-58.84%
Historical baseline
PeriodValueYoY Change
2024-53.39%-164.9%
2023-20.16%+60.5%
2022-51.07%+32.3%
2021-75.42%-65.1%
2020-45.68%-34.7%
2019-33.92%-99.9%
2018-16.97%+90.3%
2017-174.14%-